SCHEMBL564939

SCHEMBL564939

CC(C)(C)CN1c2ccccc2N(CC(C)(C)C)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
BCHE P06276 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GRM2 Q14416 1/20 0.32
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31
KDM1A O60341 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
RIPK1 Q13546 2/20 0.31
CES1 P23141 1/20 0.31
TGM2 P21980 1/20 0.31
MGLL Q99685 1/20 0.31
TAAR1 Q96RJ0 2/20 0.31
SLC6A2 P23975 2/20 0.31
MAOA P21397 1/20 0.31
LMNA P02545 3/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29422798 1.00 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C19BCHEALDH1A1
SCHEMBL12691840 0.90 CYP3A4 (0.37) CYP3A4CYP2D6CYP2C19BCHEALDH1A1
SCHEMBL8109589 0.84 MTNR1A (0.45) CYP3A4CYP2D6CYP2C19ALDH1A1PTGS1
SCHEMBL5000805 0.83 CYP2D6 (0.65) CYP3A4CYP2D6CYP2C19BCHEALDH1A1
SCHEMBL4417199 0.81 MAPT (0.42) ALDH1A1MEN1KMT2ALMNAPOLB
SCHEMBL14072265 0.81 ESR1 (0.37) CYP3A4CYP2D6CYP2C19
SCHEMBL4412748 0.78 CYP19A1 (0.38) CYP3A4CYP2D6CYP2C19ALDH1A1GRM2
SCHEMBL12691908 0.74 CYP19A1 (0.33) CYP3A4CYP2D6CYP2C19ALDH1A1LMNA
SCHEMBL17786084 0.73 CYP3A4 (0.33) CYP3A4CYP2D6CYP2C19BCHE
SCHEMBL21000355 0.73 CYP3A4 (0.33) CYP3A4CYP2D6CYP2C19BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519888-B1 COLOR EXCURSION MITIGATION IN ELECTROCHROMIC DEVICES GENTEX CORP (US) 2020-12-02 EP claimed
EP-3519888-A1 COLOR EXCURSION MITIGATION IN ELECTROCHROMIC DEVICES Gentex Corporation (US) 2019-08-07 EP claimed
US-11414595-B2 Electrochromic compounds and devices GENTEX CORPORATION (US) 2022-08-16 US disclosed
US-11194210-B2 Color excursion mitigation in electrochromic devices GENTEX CORPORATION (US) 2021-12-07 US disclosed
US-20210318584-A9 ELECTROCHROMIC COMPOUNDS AND DEVICES GENTEX CORPORATION 2021-10-14 US disclosed
US-20200379309-A1 ELECTROCHROMIC COMPOUNDS AND DEVICES GENTEX CORP (US) 2020-12-03 US disclosed
EP-3519888-B1 COLOR EXCURSION MITIGATION IN ELECTROCHROMIC DEVICES GENTEX CORP (US) 2020-12-02 EP disclosed
EP-3540505-B1 ELECTROCHROMIC THERMOPLASTICS, DEVICES, AND COMPOSITES GENTEX CORP (US) 2020-11-25 EP disclosed
US-10774198-B2 Electrochromic thermoplastics, devices, and composites GENTEX CORPORATION (US) 2020-09-15 US disclosed
EP-3177962-B1 ELECTROCHROMIC DEVICES GENTEX CORP (US) 2020-07-08 EP disclosed
EP-3540505-A2 ELECTROCHROMIC THERMOPLASTICS, DEVICES, AND COMPOSITES Gentex Corporation (US) 2019-09-18 EP disclosed
US-7428091-B2 Electrochromic compounds and associated media and devices GENTEX CORPORATION (US) 2008-09-23 US disclosed
US-7428091-B2 Electrochromic compounds and associated media and devices GENTEX CORPORATION (US) 2008-09-23 US disclosed
US-7428091-B2 Electrochromic compounds and associated media and devices GENTEX CORPORATION (US) 2008-09-23 US disclosed
US-7414770-B2 Contollably dissolving spacing member and associated electrochromic device and method for manufacturing the same GENTEX CORPORATION (US) 2008-08-19 US disclosed
WO-2007133396-A2 CONTROLLABLY DISOLVING SPACER FOR ELECTROCHROMIC DEVICES GENTEX CORPORATION (US) 2007-11-22 WO disclosed
US-20070258127-A1 Controllably dissolving spacing member and associated electrochromic device and method for manufacturing the same GENTEX CORPORATION 2007-11-08 US disclosed
EP-1812822-A2 ELECTROCHROMIC COMPOUNDS AND ASSOCIATED MEDIA AND DEVICES Gentex Corporation (US) 2007-08-01 EP disclosed
WO-2006055391-A2 ELECTROCHROMIC COMPOUNDS AND ASSOCIATED MEDIA AND DEVICES GENTEX CORPORATION (US) 2006-05-26 WO disclosed
US-20060103911-A1 Electrochromic compounds and associated media and devices GENTEX CORPORATION 2006-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210318584-A9 ELECTROCHROMIC COMPOUNDS AND DEVICES KCND2, KCNH2, KCNC1 CYP3A4 1145/4885CYP2D6 546/4885CYP2C19 996/4885
US-11414595-B2 Electrochromic compounds and devices KCND2, KCNH2, KCNC1 CYP3A4 1145/4885CYP2D6 546/4885CYP2C19 996/4885
US-20200379309-A1 ELECTROCHROMIC COMPOUNDS AND DEVICES KCND2, KCNH2, KCNC1 CYP3A4 1145/4885CYP2D6 546/4885CYP2C19 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.